Biomeme recently announced the completed acquisition of Predigen. The announcement brings together Predigen's combined decades of host response...

Biomeme is excited to announce that we have signed a definitive agreement to acquire Predigen, a spin-out from Duke University and global leader...

Biomeme’s move into its new corporate headquarters at Netrality's 401 North Broad Street, will begin an exciting new chapter for our company.  

We are pleased to announce that the U.S. Food and Drug Administration (FDA) amended Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use...

This is a very common question, so let’s get straight to it.

EDIT: As RNA viruses like SARS-CoV-2 continue to mutate, so will this panel. Please review our COVID-19 page for the latest information regarding...

We are thrilled to announce Biomeme, Inc. has been awarded a Redevelopment Assistance Capital Program (RACP) grant of $3 million from the...

List of SARS-CoV-2 Variants & Classifications

Biomeme continuously monitors and analyzes sequences of emerging variants of concern and updates...